[1]
Ahmad, A., Attique Abou Bakr, Yasir Mahmud, Raja Taha Yaseen Khan and Ghulam Abbas 2024. Comparative Validity of the ALBI Grade and CTP Score in Predicting Overall Survival in Patients Receiving TACE Plus Sorafenib Therapy for Hepatocellular Carcinoma. Journal of Health and Rehabilitation Research. 4, 2 (Jun. 2024), 1179–1184. DOI:https://doi.org/10.61919/jhrr.v4i2.913.